Midbrain dopamine neurons in Parkinson׳s disease exhibit a dysregulated miRNA and target-gene network

MicroRNAs: Target Recognition and Regulatory Functions

Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068 · see citing works

Bioconductor: open software development for computational biology and bioinformatics

Gentleman, R., Carey, V., Bates, D., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 13,133 · see citing works

limma: Linear Models for Microarray Data

Smyth, G. K. (2005) · Statistics for Biology and Health · doi:10.1007/0-387-29362-0_23 · Cited by 5,796 · see citing works

Causal analysis approaches in Ingenuity Pathway Analysis

Krämer, A., Green, J., Pollard, J., & Tugendreich, S. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt703 · Cited by 5,724 · see citing works

Bioinformatics and Computational Biology Solutions Using R and Bioconductor

Gentleman, R. C., Carey, V. J., Huber, W. K., Irizarry, R. A., & Dudoit, S. (2005) · Statistics in the health sciences · doi:10.1007/0-387-29362-0 · Cited by 3,470 · see citing works

The Beclin 1 network regulates autophagy and apoptosis

Kang, R., Zeh, H. J., Lotze, M. T., & Tang, D. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.191 · Cited by 2,485 · see citing works

lumi : a pipeline for processing Illumina microarray

Du, P., Kibbe, W. A., & Lin, S. M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn224 · Cited by 2,028 · see citing works

Epidemiology and etiology of Parkinson's disease: a review of the evidence

Wirdefeldt, K., Adami, H.-O., Cole, P., Trichopoulos, D., & Mandel, J. (2011) · European Journal of Epidemiology · doi:10.1007/s10654-011-9581-6 · Cited by 1,199 · see citing works

A MicroRNA Feedback Circuit in Midbrain Dopamine Neurons

Kim, J., Inoue, K., Ishii, J., Vanti, W. B., Voronov, S. V., Murchison, E., Hannon, G., & Abeliovich, A. (2007) · Science · doi:10.1126/science.1140481 · Cited by 1,187 · see citing works

A novel and universal method for microRNA RT-qPCR data normalization

Mestdagh, P., Van Vlierberghe, P., De Weer, A., Muth, D., Westermann, F., Speleman, F., & Vandesompele, J. (2009) · Genome Biology · doi:10.1186/gb-2009-10-6-r64 · Cited by 924 · see citing works

The Lin28/let-7 axis regulates glucose metabolism

Zhu, H., Shyh-Chang, N., Segrè, A., Shinoda, G., Shah, S. P., Einhorn, W. S., Takeuchi, A., Engreitz, J. M., Hagan, J., Kharas, M., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.033 · Cited by 907 · see citing works

Etiology and pathogenesis of Parkinson's disease

Schapira, A. H. V., & Jenner, P. G. (2011) · Movement Disorders · doi:10.1002/mds.23732 · Cited by 659 · see citing works

Repression of α-synuclein expression and toxicity by microRNA-7

Junn, E., Lee, K.-W., Jeong, B. S., Chan, T. W., Im, J.-Y., & Mouradian, M. M. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0906277106 · Cited by 634 · see citing works

Invited Article: Nervous system pathology in sporadic Parkinson disease

Braak, H., & Tredici, K. D. (2008) · Neurology · doi:10.1212/01.wnl.0000312279.49272.9f · Cited by 536 · see citing works

Post-transcriptional Regulation of α-Synuclein Expression by mir-7 and mir-153

Doxakis, E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.086827 · Cited by 485 · see citing works

MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function

Miñones-Moyano, E., Porta, S., Escaramís, G., Rabionet, R., Iraola‐Guzmán, S., Kagerbauer, B., Espinosa‐Parrilla, Y., Ferrer, I., Estivill, X., & Martı́, E. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr210 · Cited by 484 · see citing works

Regulation of the GABA cell phenotype in hippocampus of schizophrenics and bipolars

Benes, F. M., Lim, B., Matzilevich, D., Walsh, J. P., Subburaju, S., & Minns, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703806104 · Cited by 483 · see citing works

Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs

Frost, R. J., & Olson, E. N. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118922109 · Cited by 448 · see citing works

Variation in the miRNA-433 Binding Site of FGF20 Confers Risk for Parkinson Disease by Overexpression of α-Synuclein

Wang, G., van der Walt, J. M., Mayhew, G. M., Li, Y., Zuchner, S. L., Scott, W. K., Martin, E. R., & Vance, J. M. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2007.09.021 · Cited by 441 · see citing works

MicroRNA-132 Potentiates Cholinergic Anti-Inflammatory Signaling by Targeting Acetylcholinesterase

Shaked, I., Meerson, A., Wolf, Y., Avni, R., Greenberg, D., Gilboa-Geffen, A., & Soreq, H. (2009) · Immunity · doi:10.1016/j.immuni.2009.09.019 · Cited by 416 · see citing works

Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression

Gehrke, S., Imai, Y., Sokol, N. S., & Lu, B. (2010) · Nature · doi:10.1038/nature09191 · Cited by 398 · see citing works

Expression and immunolocalization of the multidrug resistance proteins, MRP1–MRP6 (ABCC1–ABCC6), in human brain

Nies, A. T., Jedlitschky, G., König, J., Herold‐Mende, C. C., Steiner, H. H., Schmitt, H.-P., & KEPPLER, D. O. R. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.051 · Cited by 381 · see citing works

Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology

Šimunović, F., Yi, M., Wang, Y., Macey, L., Brown, L. T., Krichevsky, A. M., Andersen, S. L., Stephens, R. M., Benes, F. M., & Sonntag, K. (2008) · Brain · doi:10.1093/brain/awn323 · Cited by 350 · see citing works

MicroRNAs (miRNAs) in Neurodegenerative Diseases

Nelson, P. T., Wang, W., & Rajeev, B. W. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00120.x · Cited by 325 · see citing works

Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: Targets for disease modification?

Bassil, F., Fernagut, P., Bézard, E., & Meissner, W. G. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.02.005 · Cited by 313 · see citing works

miR-155 regulates differentiation of brown and beige adipocytes via a bistable circuit

Chen, Y., Siegel, F., Kipschull, S., Haas, B., Fröhlich, H., Meister, G., & Pfeifer, A. (2013) · Nature Communications · doi:10.1038/ncomms2742 · Cited by 285 · see citing works

A neo-substrate that amplifies catalytic activity of Parkinson's-disease-related kinase PINK1

Hertz, N. T., Berthet, A., Sos, M. L., Thorn, K. S., Burlingame, A. L., Nakamura, K., & Shokat, K. M. (2013) · Cell · doi:10.1016/j.cell.2013.07.030 · Cited by 275 · see citing works

MicroRNA-205 regulates the expression of Parkinson's disease-related leucine-rich repeat kinase 2 protein

Cho, H. J., Liu, G., Jin, S. M., Parisiadou, L., Xie, C., Yu, J. H., Sun, L., Ma, B., Ding, J., Vancraenenbroeck, R., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds470 · Cited by 259 · see citing works

Reduced miR-128 in Breast Tumor–Initiating Cells Induces Chemotherapeutic Resistance via Bmi-1 and ABCC5

Zhu, Y., Yu, F., Jiao, Y., Feng, J., Tang, W., Yao, H., Gong, C., Chen, J., Su, F., Zhang, Y., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-0071 · Cited by 253 · see citing works

Roles for miRNA-378/378* in adipocyte gene expression and lipogenesis

Gerin, I., Bommer, G. T., McCoin, C. S., Sousa, K. M., Krishnan, V., & MacDougald, O. A. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00179.2010 · Cited by 251 · see citing works

Influence of miRNA in insulin signaling pathway and insulin resistance: micro‐molecules with a major role in type‐2 diabetes

Chakraborty, C., Doss, C. G. P., Bandyopadhyay, S., & Agoramoorthy, G. (2014) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1240 · Cited by 239 · see citing works

Effects of gender on nigral gene expression and parkinson disease

Cantuti‐Castelvetri, I., Keller-McGandy, C. E., Bouzou, B., Asteris, G., Clark, T. W., Frosch, M. P., & Standaert, D. G. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.02.009 · Cited by 229 · see citing works

RNA Helicases DDX5 and DDX17 Dynamically Orchestrate Transcription, miRNA, and Splicing Programs in Cell Differentiation

Dardenne, É., Espinoza, M. P., Fattet, L., Germann, S., Lambert, M.-P., Neil, H., Zonta, E., Mortada, H., Gratadou, L., Deygas, M., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.05.010 · Cited by 221 · see citing works

NF-κB Regulation: The Nuclear Response

Mankan, A. K., Lawless, M. W., Gray, S. G., Kelleher, D. P., & McManus, R. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00632.x · Cited by 190 · see citing works

Differential Glucose-Regulation of MicroRNAs in Pancreatic Islets of Non-Obese Type 2 Diabetes Model Goto-Kakizaki Rat

Esguerra, J. L. S., Bolmeson, C., Cilio, C., & Eliasson, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018613 · Cited by 186 · see citing works

Evidence for a satellite secretory pathway in neuronal dendritic spines

Pierce, J. P., Mayer, T. U., & McCarthy, J. B. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00077-x · Cited by 184 · see citing works

Inhibition of miR‐34b and miR‐34c enhances α‐synuclein expression in Parkinson's disease

Kabaria, S., Choi, D. C., Chaudhuri, A. D., Mouradian, M. M., & Junn, E. (2014) · FEBS Letters · doi:10.1016/j.febslet.2014.12.014 · Cited by 173 · see citing works

miRNA Expression Profiling: From Reference Genes to Global Mean Normalization

D′haene, B., Mestdagh, P., Hellemans, J., & Vandesompele, J. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-427-8_18 · Cited by 167 · see citing works

PINK1 protects against cell death induced by mitochondrial depolarization, by phosphorylating Bcl-xL and impairing its pro-apoptotic cleavage

Arena, G., Gelmetti, V., Torosantucci, L., Vignone, D., Lamorte, G., Rosa, P. D., Cilia, E., Jonas, E. A., & Valente, E. M. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.19 · Cited by 162 · see citing works

miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression

Yang, D., Li, T., Wang, Y., Tang, Y., Cui, H., Tang, Y., Zhang, X., Chen, D., Shen, N., & Le, W. (2012) · Journal of Cell Science · doi:10.1242/jcs.086421 · Cited by 154 · see citing works

miR-126 contributes to Parkinson's disease by dysregulating the insulin-like growth factor/phosphoinositide 3-kinase signaling

Kim, W., Lee, Y., McKenna, N. D., Yi, M., Šimunović, F., Wang, Y., Kong, B., Rooney, R. J., Seo, H., Stephens, R. M., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.01.021 · Cited by 147 · see citing works

Expression analysis of dopaminergic neurons in Parkinson’s disease and aging links transcriptional dysregulation of energy metabolism to cell death

Elstner, M., Morris, C. M., Heim, K., Bender, A., Mehta, D., Jaros, E., Klopstock, T., Meitinger, T., Turnbull, D. M., & Prokisch, H. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0828-9 · Cited by 145 · see citing works

The DEAD box proteins DDX5 (p68) and DDX17 (p72): Multi-tasking transcriptional regulators

Fuller-Pace, F. V. (2013) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2013.03.004 · Cited by 145 · see citing works

Evidence for Gender-Specific Transcriptional Profiles of Nigral Dopamine Neurons in Parkinson Disease

Šimunović, F., Yi, M., Wang, Y., Stephens, R. M., & Sonntag, K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008856 · Cited by 141 · see citing works

Review: Familial Parkinson's disease – genetics, clinical phenotype and neuropathology in relation to the common sporadic form of the disease

Schiesling, C., Kieper, N., Seidel, K., & Krüger, R. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00952.x · Cited by 135 · see citing works

MicroRNAs in metabolism and metabolic diseasesPreprint

Rottiers, V., Najafi-Shoushtari, S. H., Kristo, F., Gurumurthy, S., Zhong, L., Li, Y.-X., Cohen, D. E., Gerszten, R. E., Bardeesy, N., Mostoslavsky, R., et al. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.011049 · Cited by 130 · see citing works

Synaptic retinoic acid signaling and homeostatic synaptic plasticity

Chen, L., Lau, A. G., & Sarti, F. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.12.004 · Cited by 128 · see citing works

MicroRNAs in the regulation of TLR and RIG-I pathways

Li, Y., & Shi, X. (2012) · Cellular and Molecular Immunology · doi:10.1038/cmi.2012.55 · Cited by 125 · see citing works

MicroRNAs and deregulated gene expression networks in neurodegeneration

Sonntag, K. (2010) · Brain Research · doi:10.1016/j.brainres.2010.03.106 · Cited by 124 · see citing works

Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transporters

Wu, Q., Yang, Z., Xia, L., Nie, Y., Wu, K., Shi, Y., & Fan, D. (2014) · Oncotarget · doi:10.18632/oncotarget.2594 · Cited by 124 · see citing works

Neuroprotection of deferoxamine on rotenone-induced injury via accumulation of HIF-1α and induction of autophagy in SH-SY5Y cells

Wu, Y., Li, X., Xie, W., Jankovic, J. J., Le, W., & Pan, T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.05.008 · Cited by 115 · see citing works

Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues

Shathasivam, T., Kislinger, T., & Gramolini, A. O. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01176.x · Cited by 115 · see citing works

MicroRNA 218 Acts as a Tumor Suppressor by Targeting Multiple Cancer Phenotype-associated Genes in Medulloblastoma

Venkataraman, S., Birks, D. K., Balakrishnan, I., Alimova, I. N., Harris, P. S., Patel, P. R., Handler, M. H., Dubuc, A. M., Taylor, M. D., Foreman, N. K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.396762 · Cited by 105 · see citing works

The multifaceted role of the embryonic gene Cripto-1 in cancer, stem cells and epithelial-mesenchymal transition

Klauzińska, M., de Castro, N. P., Rangel, M. C., Spike, B. T., Gray, P. C., Bertolette, D. C., Cuttitta, F. F., & Salomon, D. S. (2014) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2014.08.003 · Cited by 104 · see citing works

Converging miRNA functions in diverse brain disorders: A case for miR-124 and miR-126

Sonntag, K., Woo, T.-U. W., & Krichevsky, A. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.11.035 · Cited by 104 · see citing works

miRNA-7-5p inhibits melanoma cell migration and invasion

Giles, K. M., Brown, R. A. M., Epis, M. R., Kalinowski, F. C., & Leedman, P. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.11.086 · Cited by 93 · see citing works

Functions of BCL-X L at the Interface between Cell Death and Metabolism

Michels, J., Kepp, O., Senovilla, L., Lissa, D., Castedo, M., Kroemer, G., & Galluzzi, L. (2013) · International Journal of Cell Biology · doi:10.1155/2013/705294 · Cited by 92 · see citing works

The over-expression of miR-200a in the hypothalamus of ob/ob mice is linked to leptin and insulin signaling impairment

Crépin, D., Benomar, Y., Riffault, L., Amine, H., Gertler, A., & Taouis, M. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.12.016 · Cited by 90 · see citing works

miR-135a targets IRS2 and regulates insulin signaling and glucose uptake in the diabetic gastrocnemius skeletal muscle

Agarwal, P., Srivastava, R., Srivastava, R., Ali, S., & Datta, M. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.03.021 · Cited by 85 · see citing works

Munc18‐1 as a key regulator of neurosecretion

Han, G. A., Malintan, N. T., Collins, B. M., Meunier, F. A., & Sugita, S. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06900.x · Cited by 83 · see citing works

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis

Heman-Ackah, S. M., Hallegger, M., Rao, M. S., & Wood, M. J. A. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00040 · Cited by 83 · see citing works

Neurotrophin/Trk receptor signaling mediates C/EBPα, -β and NeuroD recruitment to immediate-early gene promoters in neuronal cells and requires C/EBPs to induce immediate-early gene transcription

Calella, A. M., Nerlov, C., Lopez, R. G., Sciarretta, C., Halbach, O. V. B. U., Bereshchenko, O., & Minichiello, L. (2007) · Neural Development · doi:10.1186/1749-8104-2-4 · Cited by 82 · see citing works

Cancer and neurodegenerative disorders: pathogenic convergence through microRNA regulation

Du, L., & Pertsemlidis, A. (2011) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjq058 · Cited by 71 · see citing works

Lysosomal enzyme cathepsin B enhances the aggregate forming activity of exogenous α-synuclein fibrils

Tsujimura, A., Taguchi, K., Watanabe, Y., Tatebe, H., Tokuda, T., Mizuno, T., & Tanaka, M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.10.011 · Cited by 67 · see citing works

Gravin Orchestrates Protein Kinase A and β2-Adrenergic Receptor Signaling Critical for Synaptic Plasticity and Memory

Havekes, R., Canton, D. A., Park, A. J., Huang, T., Nie, T., Day, J. P., Guercio, L. A., Grimes, Q., Luczak, V., Gelman, I. H., et al. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.3612-12.2012 · Cited by 67 · see citing works

Construction and Analysis of the Protein-Protein Interaction Networks Based on Gene Expression Profiles of Parkinson's Disease

Rakshit, H., Rathi, N., & Roy, D. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103047 · Cited by 65 · see citing works

Iron deficiency alters expression of dopamine-related genes in the ventral midbrain in mice

Jellen, L. C., Lu, L., Wang, X., Unger, E. L., Earley, C. J., Allen, R. P., Williams, R. W., & Jones, B. C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.058 · Cited by 63 · see citing works

Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases

Berezin, V., Walmod, P. S., Filippov, M. A., & Dityatev, A. E. (2014) · Progress in brain research · doi:10.1016/b978-0-444-63486-3.00015-3 · Cited by 62 · see citing works

In Vitro and in Vivo Enhanced Generation of Human A9 Dopamine Neurons from Neural Stem Cells by Bcl-XL

Courtois, E. T., Castillo, C. G., Seiz, E. G., Ramos, M., Bueno, C., Liste, I., & Martı́nez-Serrano, A. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.054312 · Cited by 61 · see citing works

MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons

Kim, W., Noh, H., Lee, Y., Jeon, J., Shanmugavadivu, A., McPhie, D. L., Kim, K., Cohen, B. M., Seo, H., & Sonntag, K. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8989-x · Cited by 56 · see citing works

HOW TO CHOOSE A NORMALIZATION STRATEGY FOR MIRNA QUANTITATIVE REAL-TIME (QPCR) ARRAYS

Deo, A., Carlsson, J., & Lindlöf, A. (2011) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720011005793 · Cited by 56 · see citing works

MiRNA-145 is involved in the development of resistin-induced insulin resistance in HepG2 cells

Wen, F., Yang, Y., Jin, D., Sun, J., Yu, X., & Yang, Z. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.02.034 · Cited by 56 · see citing works

Molecular basis of axonal dysfunction and traffic impairments in CMT

Gentil, B. J., & Cooper, L. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.05.003 · Cited by 54 · see citing works

L1 neural cell adhesion molecule is a survival factor for fetal dopaminergic neurons

Hulley, P. A., Schachner, M., & L�bbert, H. (1998) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19980715)53:2 · Cited by 53 · see citing works

Polymorphisms of caffeine metabolism and estrogen receptor genes and risk of Parkinson's disease in men and women

Palacios, N., Weisskopf, M. G., Simon, K., Gao, X., Schwarzschild, M. A., & Ascherio, A. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.02.012 · Cited by 51 · see citing works

Regulation of the VHL/HIF-1 Pathway by DJ-1

Parsanejad, M. E., Zhang, Y., Qu, D., Irrcher, I., Rousseaux, M. W. C., Aleyasin, H., Kamkar, F., Callaghan, S. M., Slack, R. S., Mak, T. W., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.1244-13.2014 · Cited by 48 · see citing works

Advances with microRNAs in Parkinson’s disease research

Yuan, W., Ma, L., Wei, L. L., Wu, F., Hu, Z., & Liu, Z. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s48500 · Cited by 48 · see citing works

Munc18-1 redistributes in nerve terminals in an activity- and PKC-dependent manner

Cijsouw, T., Weber, J. P., Broeke, J. H. P., Broek, J. A. C., Schut, D., Kroon, T., Saarloos, I., Verhage, M., & Toonen, R. F. G. (2014) · The Journal of Cell Biology · doi:10.1083/jcb.201308026 · Cited by 47 · see citing works

Loss of PINK1 Attenuates HIF-1α Induction by Preventing 4E-BP1-Dependent Switch in Protein Translation under Hypoxia

Lin, W., Wadlington, N. L., Chen, L., Zhuang, X., Brorson, J. R., & Kang, U. J. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2286-13.2014 · Cited by 45 · see citing works

Vav3-deficient Mice Exhibit a Transient Delay in Cerebellar Development

Quevedo, C., Sauzeau, V., Menacho-Márquez, M., Castro-Castro, A., & Bustelo, X. R. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-04-0292 · Cited by 44 · see citing works

LIM-domain-only proteins: multifunctional nuclear transcription coregulators that interacts with diverse proteins

Sang, M., Ma, L., Sang, M., Zhou, X., Gao, W., & Geng, C. (2013) · Molecular Biology Reports · doi:10.1007/s11033-013-2952-1 · Cited by 42 · see citing works

A ‐kinase anchoring proteins: cAMP compartmentalization in neurodegenerative and obstructive pulmonary diseases

Poppinga, W. J., Muñoz-LLancao, P., González-Billault, C. E., & Schmidt, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12882 · Cited by 41 · see citing works

Over‐expression of an inactive mutant cathepsin D increases endogenous alpha‐synuclein and cathepsin B activity in SH ‐ SY 5Y cells

Crabtree, D., Dodson, M. B., Ouyang, X., Boyer‐Guittaut, M., Liang, Q., Ballestas, M. E., Fineberg, N. S., & Zhang, J. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12497 · Cited by 40 · see citing works

Analysis of Novel NEFL mRNA Targeting microRNAs in Amyotrophic Lateral Sclerosis

Ishtiaq, M., Campos‐Melo, D., Volkening, K., & Strong, M. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085653 · Cited by 38 · see citing works

L166P mutant DJ-1 promotes cell death by dissociating Bax from mitochondrial Bcl-XL

Ren, H., Fu, K., Mu, C., Zhen, X., & Wang, G. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-40 · Cited by 37 · see citing works

Vav3 Is Involved in GABAergic Axon Guidance Events Important for the Proper Function of Brainstem Neurons Controlling Cardiovascular, Respiratory, and Renal Parameters

Sauzeau, V., Horta‐Júnior, J. D. A. C., Riolobos, A. S., Fernández, G., Sevilla, M. A., López, D. E., Montero, M. J., Rico, B., & Bustelo, X. R. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-07-0639 · Cited by 36 · see citing works

Proteome analysis of ventral midbrain in MPTP‐treated normal and L1cam transgenic mice

Diedrich, M., Mao, L., Bernreuther, C., Zabel, C., Nebrich, G., KLEENE, R. B., & Klose, J. (2008) · PROTEOMICS · doi:10.1002/pmic.200700754 · Cited by 35 · see citing works

Neuronal Type-Specific Gene Expression Profiling and Laser-Capture Microdissection

Pietersen, C. Y., Lim, M. P., Macey, L., Woo, T.-U. W., & Sonntag, K. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-163-5_28 · Cited by 31 · see citing works

Variants in estrogen‐related genes and risk of Parkinson's disease

Chung, S. J., Armasu, S. M., Biernacka, J. M., Lesnick, T. G., Rider, D. N., Cunningham, J. M., & Maraganore, D. M. (2011) · Movement Disorders · doi:10.1002/mds.23604 · Cited by 27 · see citing works

Menin Is Required for Optimal Processing of the MicroRNA let-7a

Gurung, B., Muhammad, A. B., & Hua, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.520692 · Cited by 25 · see citing works

MiR-15a-16 represses Cripto and inhibits NSCLC cell progression

Chen, F., Hou, S., Fan, H., & Liu, Y.-F. (2014) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-1981-y · Cited by 21 · see citing works

The transcription factor CCAAT enhancer‐binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription‐activating isoforms

Peña‐Altamira, E., Polazzi, E., Moretto, E., Lauriola, M., & Monti, B. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12407 · Cited by 20 · see citing works

Characterization of miR-218/322-Stxbp1 pathway in the process of insulin secretion

Lang, H., Ai, Z., You, Z., Wan, Y., Guo, W. Y., Xiao, J., & Jin, X. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0305 · Cited by 17 · see citing works

Human midbrain precursors activate the expected developmental genetic program and differentiate long-term to functional A9 dopamine neurons in vitro. Enhancement by Bcl-XL

Seiz, E. G., Ramos, M., Courtois, E. T., Tønnesen, J., Kokaia, M., Liste, I., & Martı́nez-Serrano, A. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.07.018 · Cited by 16 · see citing works

Recent trends in receptor analysis techniques and instrumentation

Palacios, J. M., Mengod, G., Vilaró, M. T., & Ramm, P. (1991) · Journal of Chemical Neuroanatomy · doi:10.1016/0891-0618(91)90042-b · Cited by 16 · see citing works

Vav deficiency impedes peripheral nerve regeneration in mice

Keilhoff, G., Wiegand, S., & Fansa, H. (2012) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-2012-120230 · Cited by 9 · see citing works

miRNAs and their putative roles in the development and progression of Parkinson's disease

Wong, G., & Nass, R. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00315 · Cited by 9 · see citing works

Short Communication Huwe1 as a therapeutic target for neural injury

Zhou, J., Liu, Q., Mao, M., & Yu, T. (2014) · Genetics and Molecular Research · doi:10.4238/2014.june.9.18 · Cited by 9 · see citing works

Huwe1: A possible role in PD

Salama, M. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.05.017 · Cited by 2 · see citing works

microRNAs in Parkinson’s Disease: From Pathogenesis to Novel Diagnostic and Therapeutic Approaches

Leggio, L., Vivarelli, S., L’Episcopo, F., Tirolo, C., Caniglia, S., Testa, N., Marchetti, B., & Iraci, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122698 · Cited by 216 · see citing works

Role of MicroRNAs in Parkinson’s Disease

Goh, S. Y., Chao, Y., Dheen, S. T., Tan, E., & Tay, S. S. W. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225649 · Cited by 179 · see citing works

Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases

Sheinerman, K. S., Toledo, J. B., Tsivinsky, V. G., Irwin, D. J., Grossman, M., Weintraub, D. A., Hurtig, H. I., Chen‐Plotkin, A. S., Wolk, D. A., McCluskey, L. F., et al. (2017) · Alzheimer s Research & Therapy · doi:10.1186/s13195-017-0316-0 · Cited by 168 · see citing works

A Parkinson's disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress

Hanan, M., Simchovitz, A., Yayon, N., Vaknine, S., Cohen‐Fultheim, R., Karmon, M., Madrer, N., Rohrlich, T. M., Maman, M., Bennett, E. R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201911942 · Cited by 141 · see citing works

Erratum To: A Parkinson’s disease CircRNAs Resource reveals a link between circSLC8A1 and oxidative stress

Hanan, M., Simchovitz, A., Yayon, N., Vaknine, S., Cohen‐Fultheim, R., Karmon, M., Madrer, N., Rohrlich, T. M., Maman, M., Bennett, E. R., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202013551 · Cited by 127 · see citing works

A review of genome‐wide transcriptomics studies in Parkinson's disease

Borrageiro, G., Haylett, W. L., Seedat, S., Kuivaniemi, H., & Bardien, S. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13760 · Cited by 117 · see citing works

LncRNA SNHG1 promotes α-synuclein aggregation and toxicity by targeting miR-15b-5p to activate SIAH1 in human neuroblastoma SH-SY5Y cells

Chen, Y., Lian, Y., Ma, Y., Wu, C., Zheng, Y., & Xie, N. (2017) · NeuroToxicology · doi:10.1016/j.neuro.2017.12.001 · Cited by 102 · see citing works

Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease

Schulz, J., Takousis, P., Wohlers, I., Itua, I., Dobričić, V., Rücker, G., Binder, H., Middleton, L. T., Ioannidis, J. P. A., Perneczky, R., et al. (2019) · Annals of Neurology · doi:10.1002/ana.25490 · Cited by 99 · see citing works

MicroRNA Dysregulation in Parkinson’s Disease: A Narrative Review

Nies, Y. H., Najib, N. H. M., Lim, W. L., Kamaruzzaman, M. A., Yahaya, M. F., & Teoh, S. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.660379 · Cited by 102 · see citing works

Dicer and microRNAs protect adult dopamine neurons

Chmielarz, P., Konovalova, J., Najam, S. S., Alter, H., Piepponen, P. T., Erfle, H., Sonntag, K., Schütz, G., Vinnikov, I. A., & Domanskyi, A. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.214 · Cited by 100 · see citing works

Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases

Doroszkiewicz, J., Groblewska, M., & Mroczko, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094610 · Cited by 84 · see citing works

MicroRNA‑34a‑5p expression in the plasma and in its extracellular vesicle fractions in subjects with Parkinson's disease: An exploratory study

Grossi, I., Radeghieri, A., Paolini, L., Porrini, V., Pilotto, A., Padovani, A., Marengoni, A., Barbon, A., Bellucci, A., Pizzi, M., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4806 · Cited by 83 · see citing works

MicroRNA alterations in iPSC-derived dopaminergic neurons from Parkinson disease patients

Tolosa, E. S., Botta‐Orfila, T., Morató, X., Calatayud, C., Ferrer‐Lorente, R., Martı́, M. J., Fernández, M., Gaig, C., Raya, Á., Consiglio, A., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.05.032 · Cited by 79 · see citing works

miR-34a in Neurophysiology and Neuropathology

Chua, C. E. L., & Tang, B. L. (2018) · Journal of Molecular Neuroscience · doi:10.1007/s12031-018-1231-y · Cited by 79 · see citing works

MicroRNAs regulation in Parkinson’s disease, and their potential role as diagnostic and therapeutic targets

Shaheen, N., Shaheen, A., Osama, M., Nashwan, A. J., Bharmauria, V., & Flouty, O. E. (2024) · npj Parkinson s Disease · doi:10.1038/s41531-024-00791-2 · Cited by 77 · see citing works

Validation of human microRNA target pathways enables evaluation of target prediction tools

Kern, F., Krammes, L., Danz, K., Diener, C., Kehl, T., Küchler, O., Fehlmann, T., Kahraman, M., Rheinheimer, S., Aparicio‐Puerta, E., et al. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa1161 · Cited by 79 · see citing works

MicroRNAs in Parkinson's disease and emerging therapeutic targets

Peplow, P., & Martinez, B. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.221147 · Cited by 71 · see citing works

MicroRNAs underlying memory deficits in neurodegenerative disorders

Hernandez-Rapp, J., Rainone, S., & Hébert, S. S. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.04.011 · Cited by 72 · see citing works

Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson’s Disease: Potential Disease Biomarkers

Yang, Z., Li, T., Li, S., Wei, M., Qi, H., Shen, B., Chang, R. C., Le, W., & Piao, F. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00460 · Cited by 72 · see citing works

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative Diseases

Gentile, G., Morello, G., Cognata, V. L., Guarnaccia, M., Conforti, F. L., & Cavallaro, S. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050770 · Cited by 69 · see citing works

Back and to the Future: From Neurotoxin‐Induced to Human Parkinson's Disease Models

Airavaara, M., Parkkinen, I., Konovalova, J., Albert, K., Chmielarz, P., & Domanskyi, A. (2020) · Current Protocols in Neuroscience · doi:10.1002/cpns.88 · Cited by 61 · see citing works

From Genomics to Omics Landscapes of Parkinson's Disease: Revealing the Molecular Mechanisms

Redenšek, S., Dolžan, V., & Kunej, T. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0181 · Cited by 58 · see citing works

Nucleic Acid–Based Therapeutics for Parkinson's Disease

Nakamori, M., Junn, E., Mochizuki, H., & Mouradian, M. M. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00714-7 · Cited by 57 · see citing works

Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review

Recasens, A., Perier, C., & Sue, C. M. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00128 · Cited by 53 · see citing works

Parkinson's disease and pesticides: Are microRNAs the missing link?

Aloizou, A., Siokas, V., Sapouni, E.-M., Sita, N., Liampas, I., Brotis, A. G., Rakitskii, V. N., Burykina, T. I., Aschner, M., Bogdanos, D. P., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140591 · Cited by 53 · see citing works

Midbrain Dopaminergic Neuron Development at the Single Cell Level: In vivo and in Stem Cells

Ásgrímsdóttir, E. S., & Arenas, E. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00463 · Cited by 51 · see citing works

miR-126-5p promotes retinal endothelial cell survival through SetD5 regulation in neurons

Villain, G., Poissonnier, L., Noueihed, B., Bonfils, G., Rivera, J. C., Chemtob, S., Soncin, F., & Mattot, V. (2017) · Development · doi:10.1242/dev.156232 · Cited by 47 · see citing works

MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis

Guévremont, D., Roy, J., Cutfield, N. J., & Williams, J. M. (2023) · Scientific Reports · doi:10.1038/s41598-023-43096-9 · Cited by 48 · see citing works

Role of MicroRNAs, Aptamers in Neuroinflammation and Neurodegenerative Disorders

Khan, I., Kumari, P., Fernandes, V., Khatri, D. K., & Singh, S. B. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01093-4 · Cited by 48 · see citing works

HIF-1α/microRNA-128-3p axis protects hippocampal neurons from apoptosis via the Axin1-mediated Wnt/β-catenin signaling pathway in Parkinson’s disease models

Zhang, G., Chen, L., Liu, J., Jin, Y., Lin, Z., Du, S., Fu, Z., Chen, T., Qin, Y., Sui, F., et al. (2020) · Aging · doi:10.18632/aging.102636 · Cited by 44 · see citing works

Circular RNAs: Emblematic Players of Neurogenesis and Neurodegeneration

D’Anca, M., Buccellato, F. R., Fenoglio, C., & Galimberti, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084134 · Cited by 44 · see citing works

MicroRNA‐326 suppresses iNOS expression and promotes autophagy of dopaminergic neurons through the JNK signaling by targeting XBP1 in a mouse model of Parkinson's disease

Zhao, X., Wang, Y., Yang, J., Liu, H., & Wang, L. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28761 · Cited by 42 · see citing works

Regulatory miRNA–mRNA Networks in Parkinson’s Disease

Santos‐Lobato, B. L., Vidal, A. F., & Ribeiro‐dos‐Santos, Â. (2021) · Cells · doi:10.3390/cells10061410 · Cited by 37 · see citing works

MiR-410 exerts neuroprotective effects in a cellular model of Parkinson's disease induced by 6-hydroxydopamine via inhibiting the PTEN/AKT/mTOR signaling pathway

Ge, H., Yan, Z., Zhu, H., & Zhao, H. (2019) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2019.05.002 · Cited by 36 · see citing works

Non-Coding RNAs in the Brain-Heart Axis: The Case of Parkinson’s Disease

Acharya, S., Salgado‐Somoza, A., Stefanizzi, F. M., Lumley, A. I., Zhang, L., Glaab, E., May, P., & Devaux, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186513 · Cited by 35 · see citing works

Effects of post-learning REM sleep deprivation on hippocampal plasticity-related genes and microRNA in mice

Karabulut, S., Bayram, K. K., Bayramov, R., Daldaban, F., Topaloğlu, T., Ergen, E., Yazgan, K., Taşkıran, A. Ş., & Gölgeli, A. (2018) · Behavioural Brain Research · doi:10.1016/j.bbr.2018.12.045 · Cited by 33 · see citing works

MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson’s Disease Through Suppression of KLK7-Mediated MAPK Signaling Pathway

Zhang, Y., Xu, W., Nan, S., Chang, M., & Fan, J. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01349-1 · Cited by 33 · see citing works

Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics

Uppala, S. N., Tryphena, K. P., Naren, P., Srivastava, S., Singh, S. B., & Khatri, D. K. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111826 · Cited by 32 · see citing works

miRNA in Parkinson's disease: From pathogenesis to theranostic approaches

Elangovan, A., Venkatesan, D., Selvaraj, P., Pasha, M. Y., Babu, H. W. S., Iyer, M., Narayanasamy, A., Subramaniam, M. D., Gopalakrishnan, A. V., Kumar, N. S., et al. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30932 · Cited by 31 · see citing works

The promise of the TGF-β superfamily as a therapeutic target for Parkinson's disease

Karampetsou, M., Vekrellis, K., & Melachroinou, K. (2022) · Neurobiology of Disease · doi:10.1016/j.nbd.2022.105805 · Cited by 31 · see citing works

Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson’s Disease

Tryphena, K. P., Anuradha, U., Kumar, R., Rajan, S., Srivastava, S., Singh, S. B., & Khatri, D. K. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220449 · Cited by 30 · see citing works

Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease

Hegarty, S. V., Sullivan, A. M., & O’Keeffe, G. W. (2018) · Neuronal Signaling · doi:10.1042/ns20170181 · Cited by 29 · see citing works

Modulation of miR-181 influences dopaminergic neuronal degeneration in a mouse model of Parkinson’s disease

Stein, C. S., McLendon, J. M., Witmer, N. H., & Boudreau, R. L. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.007 · Cited by 29 · see citing works

An Overview of Epigenetic Changes in the Parkinson’s Disease Brain

Klokkaris, A., & Migdalska‐Richards, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116168 · Cited by 31 · see citing works

A High-Throughput Screening Identifies MicroRNA Inhibitors That Influence Neuronal Maintenance and/or Response to Oxidative Stress

Pallarès-Albanell, J., Zomeño-Abellán, M. T., Escaramís, G., Pantano, L., Soriano, A., Segura, M. F., & Martı́, E. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.06.007 · Cited by 27 · see citing works

MicroRNA Alterations in the Brain and Body Fluids of Humans and Animal Prion Disease Models: Current Status and Perspectives

Kanata, Ε., Thüne, K., Xanthopoulos, K., Ferrer, I., Dafou, D., Zerr, I., Sklaviadis, T., & Llorens, F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00220 · Cited by 25 · see citing works

Non-coding RNAs and their bioengineering applications for neurological diseases

Das, T., Das, T. K., Khodarkovskaya, A., & Dash, S. (2021) · Bioengineered · doi:10.1080/21655979.2021.2003667 · Cited by 24 · see citing works

The role of microRNA-485 in neurodegenerative diseases

Ryu, I. S., Kim, D. H., Cho, H., & Ryu, J. (2022) · Reviews in the Neurosciences · doi:10.1515/revneuro-2022-0039 · Cited by 24 · see citing works

Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases

Soto, M., Iranzo, Á., Lahoz, S., Fernández, M., Serradell, M., Gaig, C., Melón, P., Martı́, M. J., Santamaría, J., Camps, J., et al. (2022) · Movement Disorders · doi:10.1002/mds.29171 · Cited by 23 · see citing works

Epigenetic cerebellar diseases

Serrano, M. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64189-2.00015-9 · Cited by 22 · see citing works

MicroRNAs in the pathophysiology of Alzheimer’s disease and Parkinson's disease: an overview

Khezri, M. R., Yousefi, K., Zolbanin, N. M., & Ghasemnejad‐Berenji, M. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02727-4 · Cited by 22 · see citing works

BMP5/7 protect dopaminergic neurons in an α-synuclein mouse model of Parkinson’s disease

Vitic, Z., Safory, H., Jovanovic, V. M., Sarusi, Y., Stavsky, A., Kahn, J., Kuzmina, A., Toker, L., Gitler, D., Taube, R., et al. (2020) · Brain · doi:10.1093/brain/awaa368 · Cited by 22 · see citing works

Induction of the Endoplasmic-Reticulum-Stress Response: MicroRNA-34a Targeting of the IRE1α-Branch

Krammes, L., Hart, M., Rheinheimer, S., Diener, C., Menegatti, J., Grässer, F. A., Keller, A., & Meese, E. U. (2020) · Cells · doi:10.3390/cells9061442 · Cited by 21 · see citing works

MicroRNA expression profiles of multiple system atrophy from formalin-fixed paraffin-embedded samples

Wakabayashi, K., Mori, F., Kakita, A., Takahashi, H., Tanaka, S., Utsumi, J., & Sasaki, H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.10.034 · Cited by 20 · see citing works

Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson’s Disease

Manna, I., Quattrone, A., Benedittis, S. D., Iaccino, E., & Quattrone, A. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212726 · Cited by 19 · see citing works

Noncoding RNA Regulation of Dopamine Signaling in Diseases of the Central Nervous System

Carrick, W. T., Burks, B., Cairns, M. J., & Kocerha, J. (2016) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2016.00069 · Cited by 19 · see citing works

In silico identification of the potential molecular mechanisms involved in protective effects of prolactin on motor and memory deficits induced by 1,2-Diacetylbenzene in young and old rats

Nguyen, H. D., Jo, W. H., Hoang, N. H. M., & Kim, M. (2022) · NeuroToxicology · doi:10.1016/j.neuro.2022.09.002 · Cited by 19 · see citing works

Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases

Stoccoro, A. (2025) · Biology · doi:10.3390/biology14010098 · Cited by 17 · see citing works

Identification of microRNAs for the early diagnosis of Parkinson’s disease and multiple system atrophy

Yan, J., Hua, P., Chen, Y., Li, L., Yu, C., Yan, L., Zhang, H., He, Y., Zheng, H., Chen, H., et al. (2020) · Journal of Integrative Neuroscience · doi:10.31083/j.jin.2020.03.163 · Cited by 17 · see citing works

The Impact of microRNAs on Mitochondrial Function and Immunity: Relevance to Parkinson’s Disease

Guedes, B. F. S., Cardoso, S. M., & Esteves, A. R. (2023) · Biomedicines · doi:10.3390/biomedicines11051349 · Cited by 16 · see citing works

Unraveling the role of miRNAs in the diagnosis, progression, and therapeutic intervention of Parkinson’s disease

Mohammed, O. A., Elballal, M. S., El-Husseiny, A. A., Khidr, E. G., Tabaa, M. M. E., Elazazy, O. E., Abd‐Elmawla, M. A., Elesawy, A. E., Ibrahim, H. M., Abulsoud, A. I., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155023 · Cited by 16 · see citing works

Could α-Synuclein Modulation of Insulin and Dopamine Identify a Novel Link Between Parkinson’s Disease and Diabetes as Well as Potential Therapies?

Vidal-Martínez, G., Yang, B. C., Vargas‐Medrano, J., & Perez, R. G. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00465 · Cited by 15 · see citing works

Gender differences in microRNA expression in levodopa-naive PD patients

Vallelunga, A., Iannitti, T., Somma, G., Russillo, M. C., Picillo, M., Micco, R. D., Vacca, L., Cilia, R., Cicero, C., Zangaglia, R., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11707-0 · Cited by 14 · see citing works

Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases

Zhang, J., Chen, Z., Chen, H., Deng, Y., Li, S., & Jin, L. J. (2022) · Biosensors · doi:10.3390/bios12121074 · Cited by 13 · see citing works

Comprehensive miRNome-Wide Profiling in a Neuronal Cell Model of Synucleinopathy Implies Involvement of Cell Cycle Genes

Findeis, E., Schwarz, S. C., Evsyukov, V., Rösler, T. W., Höllerhage, M., Chakroun, T., Nykänen, N.-P., Shen, Y., Wurst, W., Kohl, M., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.561086 · Cited by 13 · see citing works

Noncoding RNA therapeutics for substance use disorder

Seyednejad, S. A., & Sartor, G. C. (2022) · Advances in Drug and Alcohol Research · doi:10.3389/adar.2022.10807 · Cited by 13 · see citing works

Novel diagnostic biomarkers related to immune infiltration in Parkinson’s disease by bioinformatics analysis

Zhang, P., Zhao, L., Li, H., Shen, J., Li, H., & Xing, Y. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1083928 · Cited by 12 · see citing works

Exosomal microRNAs in Parkinson’s disease: insights into biomarker potential and disease pathology

Chandran, D., Krishnan, S., Urulangodi, M., & Gopala, S. (2024) · Neurological Sciences · doi:10.1007/s10072-024-07439-2 · Cited by 12 · see citing works

The Role of MicroRNA in the Pathogenesis and Diagnostics of Parkinson’s Disease

Ardashirova, N. S., Fedotova, E. Y., & Illarioshkin, S. N. (2020) · Neurochemical Journal · doi:10.1134/s1819712420020026 · Cited by 12 · see citing works

Promising biomarkers and therapeutic targets for the management of Parkinson's disease: recent advancements and contemporary research

Khan, M. A., Haider, N., Singh, T., Bandopadhyay, R., Ghoneim, M. M., Alshehri, S., Taha, M., Ahmad, J., & Mishra, A. (2023) · Metabolic Brain Disease · doi:10.1007/s11011-023-01180-z · Cited by 12 · see citing works

Genetic Architecture of Parkinson’s Disease

Shadrina, M. I., & Slominsky, P. A. (2023) · Biochemistry (Moscow) · doi:10.1134/s0006297923030100 · Cited by 12 · see citing works

Identification of Hub Genes and Potential Molecular Pathogenesis in Substantia Nigra in Parkinson’s Disease via Bioinformatics Analysis

Zhou, Y., Li, Z., Chi, C., Li, C., Yang, M., & Liu, B. (2023) · Parkinson s Disease · doi:10.1155/2023/6755569 · Cited by 11 · see citing works

Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues

Vasconcelos, C. F. M., Ribas, V. T., & Petrs‐Silva, H. (2023) · Cells · doi:10.3390/cells12172155 · Cited by 11 · see citing works

Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols

Cao, X., Cui, X., & Badehnoosh, B. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70696 · Cited by 10 · see citing works

lncRNA Sequencing Reveals Neurodegeneration-Associated FUS Mutations Alter Transcriptional Landscape of iPS Cells That Persists in Motor Neurons

Provasek, V. E., Kodavati, M. M., Guo, W., Wang, H., Boldogh, I. R., Bosch, L. V. D., Britz, G. W., & Hegde, M. L. (2023) · Cells · doi:10.3390/cells12202461 · Cited by 9 · see citing works

A workflow for the integrative transcriptomic description of molecular pathology and the suggestion of normalizing compounds, exemplified by Parkinson’s disease

Hamed, M., Gladbach, Y. S., Möller, S., Fischer, S., Ernst, M., Struckmann, S., Storch, A., & Fuellen, G. (2018) · Scientific Reports · doi:10.1038/s41598-018-25754-5 · Cited by 9 · see citing works

Inhibition of miR-96-5p May Reduce Aβ42/Aβ40 Ratio via Regulating ATP-binding cassette transporter A1

Zhu, M., Jia, L., & Jia, J. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-210411 · Cited by 9 · see citing works

Orchestration of a blood-derived and ADARB1-centred network in Alzheimer's and Parkinson's disease

Song, Z., Ding, Q., & Yang, Y. X. (2023) · Cellular Signalling · doi:10.1016/j.cellsig.2023.110845 · Cited by 8 · see citing works

Meta-analyses identify differentially expressed microRNAs in Parkinson’s diseasePreprint

Schulz, J., Takousis, P., Wohlers, I., Itua, I., Dobričić, V., Rücker, G., Binder, H., Middleton, L. T., Ioannidis, J. P. A., Perneczky, R., et al. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/253849 · Cited by 8 · see citing works

Can we treat neurodegenerative diseases by preventing an age-related decline in microRNA expression?

Vinnikov, I. A., & Domanskyi, A. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.217328 · Cited by 7 · see citing works

miRNA family miR-29 inhibits PINK1-PRKN dependent mitophagy via ATG9APreprint

Markham, B. N., Ramnarine, C., Kim, S., Grever, W. E., Soto‐Beasley, A. I., Heckman, M. G., Ren, Y., Osborne, A. C., Bhagwate, A. V., Liu, Y., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.01.17.576122 · Cited by 7 · see citing works

A Comprehensive Study of miRNAs in Parkinson’s Disease: Diagnostics and Therapeutic Approaches

Siddique, Y. H., & Owais, S. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220111152756 · Cited by 6 · see citing works

Using Extracellular miRNA Signatures to Identify Patients with LRRK2-Related Parkinson’s Disease

Braunger, L. J., Knab, F., & Gasser, T. (2024) · Journal of Parkinson s Disease · doi:10.3233/jpd-230408 · Cited by 6 · see citing works

Laser microdissection and gene expression profiling in the human postmortem brain

Sonntag, K., & Woo, T.-U. W. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63639-3.00018-9 · Cited by 5 · see citing works

Identification of gene-level methylation for disease prediction

Augustine, J., & Jereesh, A. S. (2023) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-023-00584-w · Cited by 5 · see citing works

MicroRNA Expression Profile Changes in the Leukocytes of Parkinson’s Disease Patients

Ardashirova, N. S., Abramycheva, N. Y., Fedotova, E. Y., & Illarioshkin, S. N. (2022) · Acta Naturae · doi:10.32607/actanaturae.11729 · Cited by 5 · see citing works

Dopamine binds calmodulin during autoregulation of dopaminergic D2 receptor signaling through CaMKIIα-calmodulin complex

Laoye, B. J., Okurumeh, O. A., Obagaye, O. V., Olagunju, M. O., Bankole, O. O., Olubiyi, O. O., & Ogundele, O. M. (2015) · Journal of Receptors and Signal Transduction · doi:10.3109/10799893.2015.1091476 · Cited by 5 · see citing works

Functional and molecular early enteric biomarkers for Parkinson’s disease in mice and menPreprint

Gries, M., Christmann, A., Schulte, S., Weyland, M., Rommel, S., Martin, M., Baller, M. K., Röth, R., Schmitteckert, S., Unger, M. M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.06.136556 · Cited by 5 · see citing works

The Role of miRNAs in Parkinson’s Disease: A Systematic Review

Chrysanthou, M., Christodoulou, C. C., & Papanicolaou, E. Z. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262412164 · Cited by 4 · see citing works

Cell Type-Specific Laser Capture Microdissection for Gene Expression Profiling in the Human Brain

Mauney, S. A., Woo, T.-U. W., & Sonntag, K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7558-7_11 · Cited by 4 · see citing works

Roles of microRNAs in Parkinson’s and other neurodegenerative diseases

Lai, Q., Murgia, N., Parkkinen, I., Domanskyi, A., & Vinnikov, I. A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815669-8.00008-7 · Cited by 4 · see citing works

Emerging roles of circular RNAs and enhancer RNAs: new insights into the development and management of neurodegenerative disorders

Ziaei, A., Kargar, M., Shirvani-Farsani, Z., & MehrabMohseni, M. (2026) · Biomarker Research · doi:10.1186/s40364-025-00886-9 · Cited by 3 · see citing works

Relationship of Antiviral Proteins with Retroelements in the Brain in Pathogenesis of Neurodegenerative Diseases

Mustafin, R. N. (2025) · Current Proteomics · doi:10.2174/0115701646349195250327051422 · Cited by 3 · see citing works

Cellular and Extracellular MicroRNA Dysregulation in LRRK2-Linked Parkinson’s Disease

Knab, F., Lee, J.-H., Nirujogi, R. S., Menden, K., Braunger, L. J., Logarnudi, L., Riebenbauer, B., Işık, F. B., Rajkumar, A. P., Czemmel, S., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05379-2 · Cited by 3 · see citing works

Integration of small RNAs from plasma and cerebrospinal fluid for classification of multiple sclerosis

Needhamsen, M., Khoonsari, P. E., Zheleznyakova, G. Y., Piket, E., Hagemann-Jensen, M., Han, Y., Gierlich, J., Ekman, D. S., & Jagodic, M. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1042483 · Cited by 3 · see citing works

Extracellular vesicle microRNA-mediated transcriptional regulation may contribute to dementia with Lewy bodies molecular pathology

Işık, F. B., Knight, H. M., & Rajkumar, A. P. (2023) · Acta Neuropsychiatrica · doi:10.1017/neu.2023.27 · Cited by 3 · see citing works

MicroRNAs in neurodegenerative diseases: from molecular mechanisms to clinical biomarkers, detection methods and therapeutic strategies—advances and challenges

Azam, H. M. H., Mumtaz, M., Rödiger, S., Schierack, P., Hussain, N., & Ambreen, A. (2025) · Neurological Sciences · doi:10.1007/s10072-025-08419-w · Cited by 3 · see citing works

Actinomyces viscosus promotes neuroprotection in C. elegans models of Parkinson’s disease

Ngana, G. S., Bernardo, M. A. D., Surette, M. G., & MacNeil, L. T. (2025) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2025.112061 · Cited by 3 · see citing works

Epigenetic Alterations of Cognition Functions in Parkinson's DiseasePreprint

Hasani, F., Ahmadi, P., Masrour, M., Khamaki, S., Rahmati, R., & Surguchov, A. P. (2024) · Preprints.org · doi:10.20944/preprints202406.0981.v1 · Cited by 1 · see citing works

In silico analysis of hub genes and regulatory networks implicates the putamen in non-motor Parkinson’s disease disorders

Akanbi, S. T., Yusuf, J. A., Ayandele, T. O., Oladipupo, D. S., Olorunlowu, D. R., Olawuyi, B. D., Adepoju, J., Opasina, D. E., Opoola, E. K., Ugwuanyi, U. V., et al. (2025) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-025-00643-5 · Cited by 1 · see citing works

Protein Succination Is Increased in a Model of Leigh Syndrome

Piroli, G. G., Capps', A. C., Manuel, A. M., Baatz, J. E., Palmiter, R. D., Quintana, A., & Frizzell, N. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.10.086

Regulatory miRNA–mRNA Networks in Parkinson’s Disease

Santos‐Lobato, B. L., Vidal, A. F., & Ribeiro‐dos‐Santos, Â. (2021) · Cells · doi:10.3390/cells10061410 · Cited by 37 · see citing works

RISC in PD: the impact of microRNAs in Parkinson's disease cellular and molecular pathogenesis

Heman-Ackah, S. M., Hallegger, M., Rao, M. S., & Wood, M. J. A. (2013) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2013.00040 · Cited by 83 · see citing works

miRNA in Parkinson's disease: From pathogenesis to theranostic approaches

Elangovan, A., Venkatesan, D., Selvaraj, P., Pasha, M. Y., Babu, H. W. S., Iyer, M., Narayanasamy, A., Subramaniam, M. D., Gopalakrishnan, A. V., Kumar, N. S., et al. (2022) · Journal of Cellular Physiology · doi:10.1002/jcp.30932 · Cited by 31 · see citing works

Gender differences in microRNA expression in levodopa-naive PD patients

Vallelunga, A., Iannitti, T., Somma, G., Russillo, M. C., Picillo, M., Micco, R. D., Vacca, L., Cilia, R., Cicero, C., Zangaglia, R., et al. (2023) · Journal of Neurology · doi:10.1007/s00415-023-11707-0 · Cited by 14 · see citing works